Following the mass layoffs, labeled “the Valentine’s Day Massacre” by some, many have expressed concern with how the move could impact patient care, AI research and more.

The technique highlights differences in how water molecules move through cancerous tissue in comparison to healthy tissue.

Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury. 

“These findings raise the question of whether insurance reimbursement impacts referral patterns for other conditions and specialties, and the extent to which it may outweigh evidence-based care decisions."

New findings are calling into question the notion that white matter hyperintensities are biomarkers of brain injuries. 

Although the vast majority of nodules are benign, many are referred for biopsy as a precaution to rule out malignancy.

Healthcare consumers are wary of healthcare systems packing AI. 

Radiologists with Harvard Medical School gave guidance to peers in a perspective piece published Tuesday in Academic Radiology. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.